DENALI THERAPEUTICS
Denali Therapeutics is a biotechnology company focused on the discovery and development of therapies for patients with neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, ALS and others. Denali was founded by scientists, industry experts and investors who share the vision that recent scientific insights into the genetic causes and biological processes underlying neurodegenerative disease, together with new translational medicine tools, offer an unprecedented opportunity to discover and develop effective medicines. Denali is rigorously pursuing a science-driven approach to translational medicine and clinical development.
DENALI THERAPEUTICS
Social Links:
Industry:
Biotechnology Genetics Health Diagnostics Therapeutics
Founded:
2013-10-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.denalitherapeutics.com
Total Employee:
251+
Status:
Active
Total Funding:
347 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Domain Not Resolving IPv6 Google Maps Amazon Route 53 Amazon S3 Typekit Amazon SSL
Similar Organizations
Cofactor Genomics
Cofactor Genomics builds multidimensional models of disease to deliver true precision medicine.
ReviR Therapeutics
ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Baillie Gifford
Baillie Gifford investment in Series B - Denali Therapeutics
ARCH Venture Partners
ARCH Venture Partners investment in Series B - Denali Therapeutics
F-Prime Capital
F-Prime Capital investment in Series B - Denali Therapeutics
Flagship Pioneering
Flagship Pioneering investment in Series B - Denali Therapeutics
Alaska Permanent Fund
Alaska Permanent Fund investment in Series B - Denali Therapeutics
Eight Roads Ventures
Eight Roads Ventures investment in Venture Round - Denali Therapeutics
Alaska Permanent Fund
Alaska Permanent Fund investment in Series A - Denali Therapeutics
Biomatics Capital Partners
Biomatics Capital Partners investment in Series A - Denali Therapeutics
ARCH Venture Partners
ARCH Venture Partners investment in Series A - Denali Therapeutics
Flagship Pioneering
Flagship Pioneering investment in Series A - Denali Therapeutics
Key Employee Changes
Official Site Inspections
http://www.denalitherapeutics.com Semrush global rank: 2.53 M Semrush visits lastest month: 6.94 K
- Host name: ec2-44-234-240-195.us-west-2.compute.amazonaws.com
- IP address: 44.234.240.195
- Location: Boardman United States
- Latitude: 45.8491
- Longitude: -119.7143
- Metro Code: 810
- Timezone: America/Los_Angeles
- Postal: 97818
